Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The safety risks of innovation: the FDA's Expedited Drug Development Pathway.

× No keyword cloud information.

6 in total

Review 1. The risks of risk aversion in drug regulation.

Authors: Hans-Georg Eichler; Brigitte Bloechl-Daum; Daniel Brasseur; Alasdair Breckenridge; Hubert Leufkens; June Raine; Tomas Salmonson; Christian K Schneider; Guido Rasi
Journal: Nat Rev Drug Discov Date: 2013-11-15 Impact factor: 84.694

2. Post-approval safety issues with innovative drugs: a European cohort study.

Authors: Peter G M Mol; Arna H Arnardottir; Domenico Motola; Patrick J Vrijlandt; Ruben G Duijnhoven; Flora M Haaijer-Ruskamp; Pieter A de Graeff; Petra Denig; Sabine M J M Straus
Journal: Drug Saf Date: 2013-11 Impact factor: 5.606

3. Breakthrough Drug Approval Process and Postmarketing ADR Reporting.

Authors: Danial E Baker
Journal: Hosp Pharm Date: 2013-11

4. Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology Drugs.

Authors: Chul Kim; Vinay Prasad
Journal: Mayo Clin Proc Date: 2016-05-10 Impact factor: 7.616

5. The Role of Vitamin D in the Pathogenesis of Adolescent Idiopathic Scoliosis.

Authors: Shu-Yan Ng; Josette Bettany-Saltikov; Irene Yuen Kwan Cheung; Karen Kar Yin Chan
Journal: Asian Spine J Date: 2018-10-16

6. Drug Safety Monitoring in Children: Performance of Signal Detection Algorithms and Impact of Age Stratification.

Authors: Osemeke U Osokogu; Caitlin Dodd; Alexandra Pacurariu; Florentia Kaguelidou; Daniel Weibel; Miriam C J M Sturkenboom
Journal: Drug Saf Date: 2016-09 Impact factor: 5.606

6 in total